Plaintiff:	Clifton Gibson
Defendant:	Chattem, Inc., Appco Pharma LLC, Boehringer Ingelheim Pharmaceuticals, Inc, GlaxoSmithKline LLC, Pfizer Inc, Sanofi US Services Inc., Boehringer Ingelheim USA Corporation, Sanofi-Aventis U.S. LLC, McKesson Corporation, Cardinal Health, Inc., Teva Pharmaceuticals U.S.A., Inc., Granules USA, Inc., Ajanta Pharma USA Inc., Golden State Medical Supply, Inc., GlaxoSmithKline (America) Inc., Wockhardt USA LLC, Glenmark Pharmaceuticals, Inc. USA, Amneal Pharmaceuticals of New York, LLC, L. Perrigo Co., Mylan Pharmaceuticals, Inc., AmerisourceBergen Corporation, Dr. Reddy's Laboratories Inc., Geri-Care Pharmaceuticals Corp., Wockhardt USA, Inc., Boehringer Ingelheim Corporation, Ranbaxy, Inc., Par Pharmaceutical Inc., Sun Pharmaceutical Industries, Inc., Strides Pharma, Inc., Apotex Corporation, Aurobindo Pharma USA, Inc., Novitium Pharma LLC, Sandoz Inc. and Denton Pharma Inc. doing business as Northwind Pharmaceuticals
Case Number:	9:2020cv82303
Filed:	December 15, 2020
Court:	US District Court for the Southern District of Florida
Presiding Judge:	Bruce E Reinhart
Referring Judge:	Robin L Rosenberg
Nature of Suit:	Tort Product Liability
Cause of Action:	28 U.S.C. § 1332
Jury Demanded By:	Plaintiff

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System

• Search for Party Aliases
• Associated Cases
• Attorneys
• Case File Location
• Case Summary
• Docket Report
• History/Documents
• Parties
• Related Transactions
• Check Status